Prevalence of nephrocalcinosis in pseudohypoparathyroidism: Is screening necessary?

Clinical practice for evaluating uncommon conditions frequently follows care pathways established by a combination of tradition, local convention, best reasoning from pathophysiologic knowledge, expert opinion, and trade-offs of testing cost and invasiveness with the potential knowledge to be gained and the risk of missing actionable information—among other considerations. Therefore, data to better inform clinical decision making in uncommon conditions is most welcome.

https://ift.tt/2uX6zZz